Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda (Q38878886)

7 September 2017

title

Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda (English)

1 reference

7 September 2017

0 references

anti-retroviral agent

0 references

author name string

Paul J Weidle

1

1 reference

7 September 2017

Nafuna Wamai

2

1 reference

7 September 2017

Peter Solberg

3

1 reference

7 September 2017

Cheryl Liechty

4

1 reference

7 September 2017

Sam Sendagala

5

1 reference

7 September 2017

Willy Were

6

1 reference

7 September 2017

Jonathan Mermin

7

1 reference

7 September 2017

Kate Buchacz

8

1 reference

7 September 2017

Prosper Behumbiize

9

1 reference

7 September 2017

Ray L Ransom

10

1 reference

7 September 2017

Rebecca Bunnell

11

1 reference

7 September 2017

language of work or name

English

0 references

publication date

1 November 2006

1 reference

7 September 2017

1 reference

7 September 2017

volume

368

1 reference

7 September 2017

issue

9547

1 reference

7 September 2017

page(s)

1587-1594

1 reference

Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969118-6

7 January 2021

Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969118-6

7 January 2021

Adherence to first-line antiretroviral regimens in Rwanda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969118-6

7 January 2021

Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969118-6

7 January 2021

Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969118-6

7 January 2021

Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969118-6

7 January 2021

Adherence is not a barrier to successful antiretroviral therapy in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969118-6

7 January 2021

Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969118-6

7 January 2021

Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969118-6

7 January 2021

No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969118-6

7 January 2021

Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969118-6

7 January 2021

Effect of home-based water chlorination and safe storage on diarrhea among persons with human immunodeficiency virus in Uganda.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969118-6

7 January 2021

Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969118-6

7 January 2021

Free antiretrovirals must not be restricted only to treatment-naive patients. Experience in Uganda suggests that restricting access is not the way forward

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969118-6

7 January 2021

The assessment of refill compliance using pharmacy records: methods, validity, and applications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969118-6

7 January 2021

Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969118-6

7 January 2021

Long-term experience providing antiretroviral drugs in a fee-for-service HIV clinic in Uganda: evidence of extended virologic and CD4+ cell count responses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969118-6

7 January 2021

Antiretroviral therapy in public and private routine health care clinics in Cameroon: lessons from the Douala antiretroviral (DARVIR) initiative.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969118-6

7 January 2021

Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969118-6

7 January 2021

Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969118-6

7 January 2021

10.1016/S0140-6736(06)69118-6

Identifiers

DOI

1 reference

7 September 2017

1 reference